Ramkissoon, Lori A.
Britt, Nicholas
Guevara, Alexander
Whitt, Emily
Severson, Eric
Sathyan, Pratheesh
Gay, Laurie
Elvin, Julia
Ross, Jeffrey S.
Brown, Charlotte
Stogner-Underwood, Kimberly
Mott, Ryan
Kram, David
Strowd, Roy
Lesser, Glenn J.
Ramkissoon, Shakti H.
Article History
First Online: 21 June 2018
Compliance with Ethical Standards
:
: Lori A. Ramkissoon declares that she has no conflict of interest.Nicholas Britt was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Alexander Guevara was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Emily Whitt was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Eric Severson was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Pratheesh Sathyan was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Laurie Gay was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Julia Elvin was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Jeffrey S. Ross was affiliated with Foundation Medicine at the time this article was written, and therefore received compensation accordingly, and is also a stock owner.Charlotte Brown was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.Kim Stogner-Underwood declares that she has no conflict of interest.Ryan Mott declares that he has no conflict of interest.David Kram declares that he has no conflict of interest.Roy Strowd declares that he has no conflict of interest.Glenn J. Lesser has received clinical trial support from Novartis, Vascular Biogenics, Incyte, Pfizer, NovoCure, NewLink Genetics, and Orbus; has served as chair of the Data Safety Monitoring Board for Stemline Therapeutics; and has served on a consultant board for Insys Therapeutics.Shakti H. Ramkissoon was affiliated with Foundation Medicine at the time this article was written and therefore received compensation accordingly.
: This article does not contain any studies with human or animal subjects performed by any of the authors.